Scherwin Talimi

University of Zurich

Papers

1

Total Citations

76

H-Index

1

About

Scherwin Talimi is a pioneering urologic surgeon and researcher whose work has significantly advanced the field of robotic-assisted minimally invasive surgery, particularly in the management of prostate cancer. His key research areas encompass surgical oncology, robotic urology, and the refinement of lymph node dissection techniques. Talimi’s major contribution lies in the standardization and validation of robotic-assisted laparoscopic extended pelvic lymph node dissection (ePLND), a critical procedure for staging and treating high-risk prostate cancer. His landmark 2008 paper, detailing the surgical technique and outcomes from the first 99 cases, has garnered 76 citations and remains a foundational reference for surgeons worldwide. This work demonstrated the feasibility, safety, and oncologic efficacy of the robotic approach, helping to establish it as a gold standard. Beyond this, Talimi’s research has shaped best practices in pelvic lymphadenectomy, influencing surgical guidelines and improving patient outcomes. His contributions have been recognized through numerous invited lectures and surgical training programs, cementing his legacy as a key figure in the evolution of robotic urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
76
Total Citations
76
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Surgical Technique and Experience with the First 99 Cases
76 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Zurich

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago